Hundai Bioscience Offers Free Supply Of XAFTY And Funding To Support WHO Led Ebola Clinical Trials
Hyundai Bioscience USA has pledged to provide its broad-spectrum antiviral candidate, XAFTY (CP-COV03), free of charge— along with full funding for rapid clinical trials—to support the World Health Organization (WHO) and African health authorities …